DrugPatentWatch Database Preview
Pharmacia Company Profile
What is the competitive landscape for PHARMACIA, and what generic alternatives to PHARMACIA drugs are available?
PHARMACIA has one hundred and thirty-six approved drugs.
There are eight US patents protecting PHARMACIA drugs.
Summary for Pharmacia
| US Patents: | 8 |
| Tradenames: | 111 |
| Ingredients: | 86 |
| NDAs: | 136 |
| Patent Litigation for Pharmacia: | See patent lawsuits for Pharmacia |
Drugs and US Patents for Pharmacia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | HALOTESTIN | fluoxymesterone | TABLET;ORAL | 010611-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmacia And Upjohn | MYCIFRADIN | neomycin sulfate | SOLUTION;ORAL | 050285-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmacia And Upjohn | CLEOCIN T | clindamycin phosphate | GEL;TOPICAL | 050615-001 | Jan 7, 1987 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmacia And Upjohn | CORTISONE ACETATE | cortisone acetate | TABLET;ORAL | 008126-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmacia And Upjohn | GLYNASE | glyburide | TABLET;ORAL | 020051-004 | Sep 24, 1993 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmacia And Upjohn | LINCOCIN | lincomycin hydrochloride | INJECTABLE;INJECTION | 050317-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmacia And Upjohn | CLEOCIN HYDROCHLORIDE | clindamycin hydrochloride | CAPSULE;ORAL | 050162-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Pharmacia
Paragraph IV (Patent) Challenges for PHARMACIA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 600 mg | ➤ Subscribe | 2005-12-21 |
| ➤ Subscribe | Injection | 2 mg/mL, 300 mL bag | ➤ Subscribe | 2009-09-01 |
| ➤ Subscribe | Tablets | 1 g | ➤ Subscribe | 2005-08-23 |
| ➤ Subscribe | Extended-release Capsules | 2 mg and 4 mg | ➤ Subscribe | 2007-07-30 |
| ➤ Subscribe | Oral Suspension | 100 mg/5 mL | ➤ Subscribe | 2009-08-03 |
| ➤ Subscribe | Injection | 2 mg/mL, 100 mL bag | ➤ Subscribe | 2009-12-29 |
Non-Orange Book US Patents for Pharmacia
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,444,813 | Linezolid-crystal form II | ➤ Sign Up |
| 7,008,637 | Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder | ➤ Sign Up |
| 6,517,864 | Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Pharmacia Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1255754 | ➤ Sign Up |
| Australia | 6219800 | ➤ Sign Up |
| Norway | 20022264 | ➤ Sign Up |
| South Korea | 20070091374 | ➤ Sign Up |
| Argentina | 027815 | ➤ Sign Up |
| Brazil | 9915142 | ➤ Sign Up |
| Australia | 2001243243 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Pharmacia Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB09/026 | United Kingdom | ➤ Sign Up | PRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208 |
| C0002 | Belgium | ➤ Sign Up | PRODUCT NAME: ESTRADIOL; NAT. REGISTRATION NO/DATE: NL 18978 19960731; FIRST REGISTRATION: SE - 11783 19930305 |
| 09/012 | Ireland | ➤ Sign Up | PRODUCT NAME: QLAIRA-ESTRADIOL VALERATE/DIENOGEST; NAT REGISTRATION NO/DATE: PA1410/58/1 20090109; FIRST REGISTRATION NO/DATE: BE327792 20081103 |
| C0008 | Belgium | ➤ Sign Up | PRODUCT NAME: ESTRADIOL, HEMIHYDRATE; NAT. REGISTRATION NO/DATE: NL 19489 19941107; FIRST REGISTRATION: FR - NL 19489 19941107 |
| 00C/027 | Belgium | ➤ Sign Up | PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124 |
| C0043 | France | ➤ Sign Up | PRODUCT NAME: PEGVISOMANT; REGISTRATION NO/DATE: EU/1/02/240/001-003 20021113 |
| 70039 | Netherlands | ➤ Sign Up | PRODUCT NAME: [1R-[1 ALPHA (Z),2 BETA(R*),3 ALPHA,5ALPHA]]-7-[3,5-DIHYDROXY-2-(3-HYDROXY-5- FENYLPENTYL)CYCLOPENTYL]-5-HEPTEENZUUR, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN ESTER, IN HET BIJZONDER LATANOPROSTUM; NAT. REGISTRATION NO/DATE: RVG 21304 19970610; FIRST REGISTRATION: SE 12716 19960718 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
